melatonin has been researched along with naloxone in 63 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (38.10) | 18.7374 |
| 1990's | 19 (30.16) | 18.2507 |
| 2000's | 11 (17.46) | 29.6817 |
| 2010's | 7 (11.11) | 24.3611 |
| 2020's | 2 (3.17) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Satake, N | 2 |
| Conti, A; Maestroni, GJ | 2 |
| Giordano, M; Palermo, MS | 1 |
| Laughlin, GA; Loucks, AB; Yen, SS | 1 |
| Burin, LJ; Cardinali, DP; De Brito Sánchez, MG; Escolar, E; Golombek, DA | 1 |
| Brown, GM; Grota, LJ; Psarakis, S | 1 |
| Iwano, I; Kato, K; Kikuchi, Y; Kita, T; Miyauchi, M | 1 |
| Fisher, H; Sandyk, R | 2 |
| Mukherjee, S; Sandyk, R | 1 |
| Delitala, G; Esposti, D; Esposti, G; Fraschini, F; Fumagalli, P; Lissoni, P; Mauri, R; Morabito, F; Resentini, M; Santagostino, A | 1 |
| Gosnell, BA; Levine, AS; Morley, JE; Waggoner, DW | 1 |
| Aubert, ML; Lang, U; Rivest, RW; Sizonenko, PC; Winiger, BP | 1 |
| Hastings, MH; Herbert, J; Martensz, ND; Roberts, AC | 1 |
| Esposti, D; Esposti, G; Fraschini, F; Lissoni, P; Mauri, R; Orsenigo, L; Pescia, S; Rovelli, F; Vegetti, G | 1 |
| Esposti, D; Esposti, G; Fraschini, F; Lissoni, P; Parravicini, L | 1 |
| Lincoln, GA | 1 |
| Inoki, R; Ohkubo, T; Saito, K; Shibata, M; Takahashi, H | 1 |
| Iwano, I; Kato, K; Kikuchi, Y; Kita, T; Kizawa, I; Miyauchi, M; Oomori, K | 1 |
| Munro, AD | 1 |
| Hirst, M; Kavaliers, M; Podesta, RB; Young, B | 1 |
| Hirst, M; Kavaliers, M; Teskey, GC | 1 |
| Cardinali, DP; González Solveyra, C; Lowenstein, PR; Pereyra, EN | 1 |
| Becú, D; Cardinali, DP; Larrea, GA; Libertun, C; Somoza, GM | 1 |
| Albertson, TE; Lakin, ML; Peterson, SL; Stark, LG; Winters, WD | 1 |
| Lakin, ML; Miller, CH; Stott, ML; Winters, WD | 1 |
| Giedt, WR; Lakin, ML; Pettit, JR; Winters, WD | 1 |
| Rault, B; Saiag, B; Shacoori, V | 1 |
| Okatani, Y; Sagara, Y | 1 |
| Ikemoto, S; Nelson, E; Panksepp, J | 1 |
| Gillberg, C | 1 |
| Acuña-Castroviejo, D; Castillo, JL; del Aguila, CM; Fernández, B; Gomar, MD | 2 |
| Collin, D; Gandar, R | 1 |
| Girre, A; Lemay, V; Rault, B; Saïag, B; Shacoori, V | 1 |
| Aurich, C; Aurich, JE; Hoppen, HO; Lange, J | 1 |
| Akema, T; Chiba, A; Ikeda, T; Kimura, F; Nagami, Y; Toyoda, J | 1 |
| Forsling, ML; Yasin, SA | 1 |
| Akema, T; Chiba, A; Iigo, M; Kimura, F; Nagami, Y; Toyoda, J | 1 |
| Caffarri, G; Capretti, L; Chiodera, P; Coiro, V; Colla, R; Giuliani, N; Marchesi, C; Volpi, R | 1 |
| Akema, T; Chiba, A; Ikeda, T; Kimura, F; Sato, I; Sugiyama, H; Toyoda, J | 1 |
| Cao, XD; Wu, GC; Xu, SF; Yu, CX; Zhu, B | 1 |
| Arimura, A; Fürst, Z; Heinzelmann, A; Kántor, O; Köves, K; Molnár, J | 1 |
| Choi, KB; Chun, CH; Gimm, YM; Huh, IH; Jeong, JH; Sohn, UD; Sung, JY; Sung, KY; Yi, BC | 1 |
| Barcikowski, B; Misztal, T; Romanowicz, K | 2 |
| Chuchuen, U; Ebadi, M; Govitrapong, P | 1 |
| Ajjimaporn, A; Ebadi, M; Govitrapong, P; Ho, B; Klongpanichapak, S; Sawlom, S; Shavali, S | 1 |
| Misztal, T; Romanowicz, K | 1 |
| Dokmeci, D; Guray, G; Ozyigit, F; Sapolyo, N; Tamer, M; Ulugol, A | 1 |
| Wei, YM; Xu, Y; Yu, CX | 1 |
| Han, J; Wei, YM; Xu, Y; Yu, CX | 1 |
| Chiodera, P; Coiro, V; Maffei, ML; Melani, A; Volpi, R; Volta, E | 1 |
| Birdane, YO; Bulut, S; Büyükokuroğlu, ME; Cemek, M; Hazman, O; Konuk, M | 1 |
| Celi, I; Guzmán, JL; Malpaux, B; Zarazaga, LA | 1 |
| Chen, CR; Chen, L; Cheng, NN; Huang, ZL; Laudon, M; Liu, YY; Qu, WM; Urade, Y; Yin, D | 1 |
| Asai, M; Benítez-King, G; Escobar, C; Solís-Chagoyán, H; Valdés-Tovar, M | 1 |
| Bakhtazad, A; Garmabi, B; Vosough, M; Vousooghi, N; Yoonessi, A; Zarrindast, MR | 1 |
| Candeletti, S; Darcq, E; De Gregorio, D; Gobbi, G; He, Q; Kieffer, BL; Lopez-Canul, M; Luongo, L; Pearl-Dowler, L; Posa, L; Romualdi, P; Rullo, L | 1 |
| De, A; Grasing, KW | 1 |
2 review(s) available for melatonin and naloxone
| Article | Year |
|---|---|
Immuno-derived opioids as mediators of the immuno-enhancing and anti-stress action of melatonin.
Topics: Animals; beta-Endorphin; CD4-Positive T-Lymphocytes; Cells, Cultured; Drug Synergism; Enkephalin, Methionine; Immune Sera; Interleukin-2; Melatonin; Mice; Naloxone; Neuroimmunomodulation; Receptors, Opioid; Spleen; Stress, Physiological; Thymus Gland | 1991 |
[Functional hypothalamic amenorrheas. I. Physiopathology].
Topics: Amenorrhea; Corticotropin-Releasing Hormone; Female; Gonadotropin-Releasing Hormone; Humans; Hypothalamic Diseases; Luteinizing Hormone; Melatonin; Metoclopramide; Naloxone; Prolactin | 1993 |
1 trial(s) available for melatonin and naloxone
| Article | Year |
|---|---|
Different effects of naloxone on the growth hormone response to melatonin and pyridostigmine in normal men.
Topics: Administration, Oral; Adult; Human Growth Hormone; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Melatonin; Naloxone; Pyridostigmine Bromide | 1998 |
60 other study(ies) available for melatonin and naloxone
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effect of melatonin and methionine-enkephalin on surfacing responses in goldfish.
Topics: Animals; Dose-Response Relationship, Drug; Endorphins; Enkephalins; Goldfish; Melatonin; Motor Activity; Naloxone; Nociceptors; Peptides; Receptors, Opioid | 1979 |
Anti-stress role of the melatonin-immuno-opioid network: evidence for a physiological mechanism involving T cell-derived, immunoreactive beta-endorphin and MET-enkephalin binding to thymic opioid receptors.
Topics: Animals; Antibody Formation; beta-Endorphin; Cross Reactions; Enkephalin, Methionine; Female; Hemolytic Plaque Technique; Immune Sera; Lymphocyte Activation; Melatonin; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Naloxone; Pineal Gland; Prednisone; Radioimmunoassay; Receptors, Opioid; T-Lymphocytes; Thymus Gland | 1991 |
Melatonin-induced enhancement of antibody-dependent cellular cytotoxicity.
Topics: Animals; Antibody-Dependent Cell Cytotoxicity; Cytotoxicity Tests, Immunologic; Dose-Response Relationship, Drug; Female; Melatonin; Mice; Mice, Inbred BALB C; Naloxone; Pineal Gland; Spleen | 1991 |
Marked augmentation of nocturnal melatonin secretion in amenorrheic athletes, but not in cycling athletes: unaltered by opioidergic or dopaminergic blockade.
Topics: 2-Methyl-4-chlorophenoxyacetic Acid; Adult; Amenorrhea; Circadian Rhythm; Dopamine Antagonists; Exercise; Female; Hormones; Humans; Melatonin; Menstrual Cycle; Naloxone; Narcotic Antagonists; Reference Values | 1991 |
Time-dependent melatonin analgesia in mice: inhibition by opiate or benzodiazepine antagonism.
Topics: Analgesics; Animals; Benzodiazepines; Circadian Rhythm; Flumazenil; Kinetics; Light; Male; Melatonin; Mice; Naloxone; Narcotic Antagonists; Pain Measurement; Reaction Time; Time Factors | 1991 |
Analgesia induced by N-acetylserotonin in the central nervous system.
Topics: Analgesia; Animals; Cerebral Ventricles; Immune Sera; Injections, Intraperitoneal; Injections, Intraventricular; Male; Melatonin; Morphine; Naloxone; Pain Measurement; Palliative Care; Rats; Rats, Inbred Strains; Serotonin | 1988 |
Inhibition of human ovarian cancer cell proliferation in vitro by neuroendocrine hormones.
Topics: beta-Endorphin; Cell Division; Cystadenocarcinoma; DNA, Neoplasm; Dose-Response Relationship, Drug; Endorphins; Enkephalin, Methionine; Female; Fluorouracil; Humans; In Vitro Techniques; Melatonin; Naloxone; Ovarian Neoplasms; Prostaglandins D; Protein Precursors; RNA, Neoplasm; Tumor Cells, Cultured | 1989 |
Melatonin potentiates the effects of naloxone on reserpine-induced catalepsy in the rat.
Topics: Animals; Catalepsy; Drug Interactions; Female; Melatonin; Naloxone; Pineal Gland; Rats; Rats, Inbred Strains; Reserpine | 1989 |
Attenuation of reserpine-induced catalepsy by melatonin and the role of the opioid system.
Topics: Animals; Catalepsy; Endorphins; Female; Melatonin; Nalbuphine; Naloxone; Rats; Rats, Inbred Strains; Reserpine | 1989 |
Melatonin mediates the antidyskinetic effects of naloxone in tardive dyskinesia.
Topics: Animals; Dyskinesia, Drug-Induced; Male; Melatonin; Naloxone; Rats; Rats, Inbred Strains | 1989 |
A clinical study on the relationship between the pineal gland and the opioid system.
Topics: Adolescent; Adult; beta-Endorphin; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Endorphins; Female; Humans; Male; Melatonin; Naloxone; Pineal Gland; Time Factors | 1986 |
The pineal gland and opiate-induced feeding.
Topics: Animals; Butorphanol; Cyclazocine; Endorphins; Ethylketocyclazocine; Feeding Behavior; Male; Melatonin; Morphine; Naloxone; Pineal Gland; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa | 1985 |
Delayed sexual maturation induced by daily melatonin administration eliminates the LH response to naloxone despite normal responsiveness to GnRH in juvenile male rats.
Topics: Aging; Animals; Luteinizing Hormone; Male; Melatonin; Naloxone; Pituitary Hormone-Releasing Hormones; Prolactin; Rats; Rats, Inbred Strains; Receptors, Pituitary Hormone; Sexual Maturation | 1988 |
Changes in photoperiod alter the daily rhythms of pineal melatonin content and hypothalamic beta-endorphin content and the luteinizing hormone response to naloxone in the male Syrian hamster.
Topics: Animals; beta-Endorphin; Circadian Rhythm; Cricetinae; Endorphins; Gonadotropin-Releasing Hormone; Hypothalamus; Hypothalamus, Anterior; Hypothalamus, Middle; Light; Luteinizing Hormone; Male; Melatonin; Naloxone; Periodicity; Pineal Gland; Preoptic Area | 1985 |
The pineal gland-opioid system relation: melatonin-naloxone interactions in regulating GH and LH releases in man.
Topics: Adult; Drug Interactions; Female; Growth Hormone; Humans; Infusions, Intravenous; Luteinizing Hormone; Male; Melatonin; Naloxone; Pineal Gland | 1988 |
Action of morphine on melatonin release in the rat.
Topics: Animals; Male; Melatonin; Morphine; Naloxone; Pineal Gland; Rats; Rats, Inbred Strains | 1988 |
Endogenous opioids and the control of LH secretion during the reproductive cycle in the ram induced by treatment with melatonin.
Topics: Animals; Drug Implants; Endorphins; Luteinizing Hormone; Male; Melatonin; Naloxone; Reproduction; Sheep | 1988 |
Effect of neurotropin on hyperalgesia induced by prostaglandin E2, naloxone, melatonin and dark condition in mice.
Topics: Analgesics; Animals; Aspirin; Darkness; Dinoprostone; Formaldehyde; Male; Melatonin; Mice; Naloxone; Pain; Polysaccharides; Prostaglandins E | 1987 |
Inhibitory effects of neuroendocrine hormones on human ovarian cancer cell proliferation in vitro.
Topics: Cell Division; Cell Line; Endorphins; Enkephalin, Methionine; Female; Humans; Melatonin; Naloxone; Ovarian Neoplasms; Prostaglandin D2; Prostaglandins D; Tumor Cells, Cultured | 1987 |
Effects of melatonin, serotonin, and naloxone on aggression in isolated cichlid fish (Aequidens pulcher).
Topics: Aggression; Animals; Female; Melatonin; Naloxone; Perches; Perciformes; S-Adenosylhomocysteine; Serotonin; Serotonin Antagonists | 1986 |
Evidence for the activation of the endogenous opiate system in hamsters infected with human blood flukes, Schistosoma mansoni.
Topics: Analgesia; Animals; Body Temperature; Cricetinae; Kinetics; Male; Melatonin; Mesocricetus; Morphine; Naloxone; Pineal Gland; Receptors, Opioid; Schistosoma mansoni; Schistosomiasis; Time Factors | 1984 |
Ageing, opioid analgesia and the pineal gland.
Topics: Aging; Analgesia; Animals; Benserazide; Circadian Rhythm; Endorphins; Latency Period, Psychological; Male; Melatonin; Mice; Morphine; Naloxone; Photic Stimulation; Pineal Gland | 1983 |
Effect of naloxone on the nocturnal rise of rat pineal melatonin content.
Topics: Animals; Male; Melatonin; Naloxone; Pineal Gland; Rats; Rats, Inbred Strains | 1984 |
Inhibition by naloxone of the serotonin-induced prolactin release in free-moving rats.
Topics: Animals; Female; Melatonin; Movement; Naloxone; Prolactin; Rats; Serotonin; Vasotocin | 1983 |
The anticonvulsant properties of melatonin on kindled seizures in rats.
Topics: Amygdala; Animals; Anticonvulsants; Diazepam; Electric Stimulation; Male; Melatonin; Naloxone; Pentylenetetrazole; Phenobarbital; Rats; Seizures | 1981 |
Effect of methionine-enkephalin on xanthopore aggregation.
Topics: Animals; Endorphins; Enkephalin, Methionine; Enkephalins; Goldfish; Melatonin; Naloxone; Skin; Skin Physiological Phenomena | 1980 |
Involvement of the pineal gland and melatonin in murine analgesia.
Topics: Analgesia; Animals; Circadian Rhythm; Dose-Response Relationship, Drug; Male; Melatonin; Mice; Morphine; Naloxone; Pineal Gland; Reaction Time; Time Factors | 1981 |
Melatonin: pituitary action and naloxone reversed analgesia.
Topics: Analgesics; Animals; Chickens; Dose-Response Relationship, Drug; Drug Interactions; Ketamine; Light; Male; Melatonin; Naloxone; Pituitary Gland; Reaction Time | 1980 |
Melatonin modifies prolactin release induced by opiate antagonists in male rats.
Topics: Animals; Injections, Subcutaneous; Male; Melatonin; Naloxone; Naltrexone; Narcotic Antagonists; Prolactin; Quaternary Ammonium Compounds; Rats; Rats, Wistar | 1995 |
Enhanced nocturnal melatonin secretion in women with functional secondary amenorrhea: relationship to opioid system and endogenous estrogen levels.
Topics: Adolescent; Adult; Amenorrhea; Circadian Rhythm; Endorphins; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Melatonin; Naloxone; Reference Values | 1995 |
The effects of melatonin on isolation distress in chickens.
Topics: Animals; Chickens; Dextroamphetamine; Melatonin; Morphine; Naloxone; Pineal Gland; Social Isolation; Vocalization, Animal | 1994 |
Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians.
Topics: Autistic Disorder; Brain; Endorphins; Humans; Infant, Newborn; Melatonin; Naloxone; Naltrexone; Self-Injurious Behavior; Serotonin | 1995 |
Melatonin counteracts pinealectomy-dependent decreases in rat brain [3H]flunitrazepam binding through an opioid mechanism.
Topics: Animals; Brain; Endorphins; Flunitrazepam; Ganglionectomy; Injections, Intraventricular; Male; Melatonin; Membranes; Naloxone; Pineal Gland; Rats; Rats, Wistar; Superior Cervical Ganglion; Sympathetic Nervous System | 1993 |
Intracerebroventricular injection of naloxone blocks melatonin-dependent brain [3H]flunitrazepam binding.
Topics: Adrenal Cortex Hormones; Animals; beta-Endorphin; Cerebral Cortex; Dose-Response Relationship, Drug; Flunitrazepam; Hypophysectomy; In Vitro Techniques; Injections, Intraventricular; Male; Melatonin; Naloxone; Rats; Rats, Wistar; Receptors, GABA-A | 1993 |
Effects of melatonin in vivo upon luteinizing hormone and prolactin releases induced by opiate receptor antagonists in adult male rats.
Topics: Animals; Luteinizing Hormone; Male; Melatonin; Naloxone; Naltrexone; Narcotic Antagonists; Prolactin; Quaternary Ammonium Compounds; Rats; Rats, Wistar | 1996 |
Influence of melatonin and oestradiol on the opioidergic regulation of LH and prolactin release in pony mares.
Topics: Animals; Estradiol; Horses; Luteinizing Hormone; Melatonin; Naloxone; Narcotic Antagonists; Opioid Peptides; Prolactin; Seasons | 1997 |
Melatonin inhibits naloxone-induced luteinizing hormone release in ovariectomized estrogen-primed rats.
Topics: Animals; Female; Gonadotropin-Releasing Hormone; Kinetics; Luteinizing Hormone; Melatonin; Naloxone; Narcotic Antagonists; Ovariectomy; Periodicity; Rats; Rats, Wistar | 1997 |
Mechanisms of melatonin inhibition of neurohypophysial hormone release from the rat hypothalamus in vitro.
Topics: Animals; Atenolol; Atropine; Haloperidol; Hypothalamus; Ibuprofen; In Vitro Techniques; Male; Mecamylamine; Melatonin; Naloxone; Oxytocin; Phentolamine; Rats; Rats, Wistar; Receptors, Neurotransmitter; Reproducibility of Results; Vasopressins | 1998 |
A possible role of the pineal gland in acute immobilization-related suppression of naloxone-induced LH release in ovariectomized estrogen-primed rats.
Topics: Animals; Estrogens; Female; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Melatonin; Naloxone; Narcotic Antagonists; Ovariectomy; Pineal Gland; Rats; Rats, Wistar; Restraint, Physical; Stimulation, Chemical; Stress, Physiological | 1998 |
Intraventricular injection of melatonin inhibits naloxone-induced, but not NMDA- or LHRH-induced LH release in ovariectomized estrogen-primed rats.
Topics: Animals; Estradiol; Excitatory Amino Acid Agonists; Female; Gonadotropin-Releasing Hormone; Injections, Intraventricular; Luteinizing Hormone; Melatonin; N-Methylaspartate; Naloxone; Narcotic Antagonists; Ovariectomy; Rats; Rats, Wistar | 1999 |
The analgesic effects of peripheral and central administration of melatonin in rats.
Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Injections, Intraventricular; Male; Melatonin; Naloxone; Nociceptors; Pain; Rats; Rats, Sprague-Dawley | 2000 |
The inhibitory effect of PACAP38 on ovulation is mediated by CRF and endogenous opioids.
Topics: Animals; Corticotropin-Releasing Hormone; Female; Hypothalamus; Injections, Intraventricular; Luteinizing Hormone; Melatonin; Models, Biological; Naloxone; Neuropeptides; Opioid Peptides; Ovulation; Pituitary Adenylate Cyclase-Activating Polypeptide; Pituitary Gland; Rats; Rats, Sprague-Dawley; Somatostatin | 2000 |
Effects of extremely low frequency magnetic fields on pain thresholds in mice: roles of melatonin and opioids.
Topics: Animals; Circadian Rhythm; Electromagnetic Fields; Hyperalgesia; Male; Melatonin; Mice; Mice, Inbred ICR; Naloxone; Narcotic Antagonists; Pain Measurement; Pain Threshold; Postural Balance; Receptors, GABA-A; Receptors, Opioid | 2000 |
Short-term modulation of prolactin secretion by melatonin in anestrous ewes following dopamine- and opiate receptor blockade.
Topics: Anestrus; Animals; Brain; Dopamine Antagonists; Female; Melatonin; Naloxone; Narcotic Antagonists; Pituitary Gland; Prolactin; Sheep; Sulpiride | 2001 |
Effects of melatonin on luteinizing hormone secretion in anestrous ewes following dopamine and opiate receptor blockade.
Topics: Anestrus; Animals; Cerebral Ventricles; Dopamine Antagonists; Female; Luteinizing Hormone; Melatonin; Naloxone; Narcotic Antagonists; Periodicity; Photoperiod; Sheep; Sulpiride | 2004 |
The stimulatory effect of mu- and delta-opioid receptors on bovine pinealocyte melatonin synthesis.
Topics: Acetyltransferases; Analgesics, Opioid; Animals; Cattle; Cells, Cultured; Cyclic AMP; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Female; Melatonin; Naloxone; Narcotic Antagonists; Pineal Gland; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2004 |
Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid.
Topics: Analgesics; Analgesics, Opioid; Animals; beta-Endorphin; Binding, Competitive; Brain; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enzyme-Linked Immunosorbent Assay; Melatonin; Mice; Naloxone; Nociceptin; Opioid Peptides; Pineal Gland; Radioligand Assay; Rats; Receptors, Opioid; Subcellular Fractions; Time Factors; Tritium | 2005 |
Effective stimulation of daily LH secretion by the combined treatment with melatonin and naloxone in luteal-phase ewes.
Topics: Adjuvants, Immunologic; Animals; Drug Synergism; Female; Injections, Intraventricular; Luteal Phase; Luteinizing Hormone; Melatonin; Naloxone; Narcotic Antagonists; Sheep | 2005 |
Antihyperalgesic, but not antiallodynic, effect of melatonin in nerve-injured neuropathic mice: Possible involvements of the L-arginine-NO pathway and opioid system.
Topics: Analgesics; Animals; Arginine; Hyperalgesia; Injections, Intraperitoneal; Injections, Intraventricular; Melatonin; Mice; Mice, Inbred Strains; Naloxone; Narcotic Antagonists; Nitric Oxide; Receptors, Opioid; Sciatic Nerve; Sciatic Neuropathy | 2006 |
[Effect of melatonin on the content of β-endorphin in the hypothalamic arcuate nucleus and periaqueductal grey of midbrain in morphine withdrawal mice].
Topics: Animals; Arcuate Nucleus of Hypothalamus; beta-Endorphin; Male; Melatonin; Mesencephalon; Mice; Morphine Dependence; Naloxone; Periaqueductal Gray; Substance Withdrawal Syndrome | 2007 |
Melatonin enhances the expression of β-endorphin in hypothalamic arcuate nucleus of morphine-dependent mice.
Topics: Animals; Arcuate Nucleus of Hypothalamus; beta-Endorphin; Male; Melatonin; Mice; Morphine; Morphine Dependence; Naloxone; Pro-Opiomelanocortin; RNA, Messenger; Substance Withdrawal Syndrome | 2009 |
Effect of naloxone on the inhibitory effect of melatonin on the release of arginine-vasopressin induced by physical exercise in man.
Topics: Arginine Vasopressin; Drug Interactions; Exercise; Humans; Male; Melatonin; Naloxone; Radioimmunoassay | 2010 |
The roles of melatonin and vitamin E plus selenium in prevention of oxidative stress induced by naloxone-precipitated withdrawal in heroin-addicted rats.
Topics: Animals; Antioxidants; Ceruloplasmin; Glutathione; Heroin; Heroin Dependence; Lipid Peroxidation; Male; Malondialdehyde; Melatonin; Naloxone; Nitrates; Nitrites; Oxidative Stress; Rats; Rats, Sprague-Dawley; Selenium; Substance Withdrawal Syndrome; Vitamin E | 2011 |
The effect of nutrition on the neural mechanisms potentially involved in melatonin-stimulated LH secretion in female Mediterranean goats.
Topics: Animal Nutritional Physiological Phenomena; Animals; Cyproheptadine; Dopamine; Dose-Response Relationship, Drug; Female; Goats; Luteinizing Hormone; Melatonin; N-Methylaspartate; Naloxone; Neurosecretory Systems; Opioid Peptides; Pimozide; Serotonin | 2011 |
Piromelatine exerts antinociceptive effect via melatonin, opioid, and 5HT1A receptors and hypnotic effect via melatonin receptors in a mouse model of neuropathic pain.
Topics: Analgesics; Animals; Disease Models, Animal; Hyperalgesia; Hypnotics and Sedatives; Indoles; Male; Melatonin; Mice; Naloxone; Narcotic Antagonists; Neuralgia; Pain Measurement; Peripheral Nerve Injuries; Piperazines; Pyrans; Pyridines; Receptor, Serotonin, 5-HT1A; Receptors, Melatonin; Receptors, Opioid; Sciatic Nerve; Serotonin Antagonists; Sleep Wake Disorders; Tryptamines | 2014 |
Constant light suppresses production of Met-enkephalin-containing peptides in cultured splenic macrophages and impairs primary immune response in rats.
Topics: Animals; Circadian Rhythm; Cytokines; Down-Regulation; Enkephalin, Methionine; Enkephalins; Immunoglobulin M; Immunohistochemistry; Interleukin-2; Light; Macrophages; Male; Melatonin; Naloxone; Phenotype; Photoperiod; Protein Precursors; Rats; Rats, Wistar; Spleen | 2015 |
Effect of circadian rhythm disturbance on morphine preference and addiction in male rats: Involvement of period genes and dopamine D1 receptor.
Topics: Animals; Circadian Rhythm; Corpus Striatum; Disease Models, Animal; Male; Melatonin; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Period Circadian Proteins; Photic Stimulation; Prefrontal Cortex; Rats, Wistar; Receptors, Dopamine D1; RNA, Messenger; Substance Withdrawal Syndrome | 2016 |
Supraspinal melatonin MT
Topics: Analgesics, Opioid; Animals; Enkephalins; Melatonin; Mice; Naloxone; Narcotic Antagonists; Neuralgia; Rats; Receptors, Opioid, delta; Receptors, Opioid, mu | 2022 |
The antidepressant agomelatine attenuates morphine-induced reinstatement but not self-administration or precipitated withdrawal.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Male; Melatonin; Morphine; Naloxone; Narcotic Antagonists; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2023 |